Biological Implication of Cytoplasmic ECT2 in Malignant Progression of Lung Adenocarcinoma

被引：0
|
作者：
Kosibaty, Zeinab [1 ]
Murata, Yoshihiko [2 ]
Minami, Yuko [3 ]
Sakashita, Shingo [4 ]
Noguchi, Masayuki [4 ]
机构：
[1] Univ Tsukuba, Gradauate Sch Comprehens Human Sci, Ibaraki, Japan
[2] Univ Tsukuba Hosp, Dept Pathol, Ibaraki, Japan
[3] Ibarakihigashi Natl Hosp, Natl Hosp Org, Pathol, Ibaraki, Japan
[4] Univ Tsukuba, Fac Med, Dept Pathol, Ibaraki, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Prognostic Biomarker; Progression of Malignancy; Epithelial cell transforming 2 (ECT2); lung adenocarcinoma;
D O I：
10.1016/j.jtho.2016.11.1123
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-071
引用
收藏
页码：S830 / S831
页数：3
相关论文
共 50 条
  • [31] High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
    Zhou, Shijie
    Wang, Ping
    Su, Xiaolan
    Chen, Jingxia
    Chen, Hongfen
    Yang, Hanbing
    Fang, Aiping
    Xie, Linshen
    Yao, Yuqin
    Yang, Jinliang
    PLOS ONE, 2017, 12 (10):
  • [32] The Oncogene ECT2 Contributes to a Hyperplastic, Proliferative Lung Epithelial Cell Phenotype in Idiopathic Pulmonary Fibrosis
    Ulke, Henrik M.
    Mutze, Kathrin
    Lehmann, Mareike
    Wagner, Darcy E.
    Heinzelmann, Katharina
    Guenther, Andreas
    Eickelberg, Oliver
    Koenigshoff, Melanie
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 61 (06) : 713 - 726
  • [33] MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation
    Xu, Jianli
    Yao, Qi
    Hou, Yu
    Xu, Meng
    Liu, Sheng
    Yang, Longqiu
    Zhang, Lei
    Xu, Hui
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (05) : 381 - 386
  • [34] SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression
    He, Yan
    Wang, Yiyao
    Luo, Zhenyu
    Zhang, Xue
    Bai, Hua
    Wang, Jie
    CELLULAR SIGNALLING, 2024, 120
  • [35] Transcription factor ETS1-mediated ECT2 expression promotes the malignant behavior of prostate cancer cells
    Zheng, Bo
    Chen, Kuifu
    Liu, Xin
    Wan, Zhenghua
    Wu, Yulong
    Xu, Liming
    Xiao, Jiguang
    Chen, Jinqu
    ONCOLOGY LETTERS, 2024, 28 (04)
  • [36] MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma
    Li, Zhiyong
    Jiang, Danfeng
    Yang, Sheng
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 10975 - 10984
  • [37] Abnormally High Expression of DNAJB6 Accelerates Malignant Progression of Lung Adenocarcinoma
    Wang, Di
    Xiao, Jiayu
    Du, Yang
    Zhang, Li
    Qin, Xuzhen
    BIOMEDICINES, 2024, 12 (09)
  • [38] Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma
    Guo, Ai Yun
    Liang, Xu Jun
    Liu, Rui Jie
    Li, Xiao Xiao
    Bi, Wu
    Zhou, Liu Ying
    Tang, Can E.
    Yan, Ang
    Chen, Zhu Chu
    Zhang, Peng Fei
    CANCER BIOLOGY & THERAPY, 2017, 18 (09) : 715 - 722
  • [39] Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
    Zhao, Huihui
    Lu, Guojun
    FRONTIERS IN GENETICS, 2022, 13
  • [40] BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β
    Jin, Kai
    Li, Yongmeng
    Wei, Ruyuan
    Liu, Yanfei
    Wang, Shuai
    Tian, Hui
    CELL DEATH DISCOVERY, 2024, 10 (01)
12345